Market taxonomy by types classifies Custom Cell Isolation Service into magnetic‑bead, fluorescence‑activated cell sorting (FACS), microfluidic, and enzymatic approaches. Magnetic‑bead platforms dominate with an estimated 45 % share, driven by their scalability, cost‑effectiveness, and compatibility with both research and clinical workflows; they generate the bulk of transaction volume across small‑to‑medium‑sized projects. FACS, representing roughly 30 % of the market, offers high purity and multiparametric selection, which commands premium pricing in therapeutic‑cell manufacturing and advanced diagnostics. Microfluidic devices, accounting for about 15 % of revenue, enable label‑free isolation and single‑cell resolution, attracting biotech firms focused on precision assays and rare‑cell capture. Enzymatic dissociation methods, contributing the remaining 10 %, are preferred for delicate tissues where surface markers are inaccessible, supporting niche academic studies and early‑stage product development. The relative weighting of each type reflects both technological maturity and client‑specific cost‑benefit assessments, thereby influencing the aggregate market size for Custom Cell Isolation Service.